A Real-life study of Alemtuzumab in patients with Multiple Sclerosis: Kuwait's Experience

Authors
Category Primary study
JournalNeurology
Year 2023
This article has no abstract
Epistemonikos ID: 025832ed2ecf90ba0982f5239ce371952fce00e2
First added on: Feb 16, 2025